Cargando…
Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies
[Image: see text] Microtubule (MT) stabilizing drugs hold promise as potential treatments for Alzheimer’s disease (AD) and related tauopathies. However, thus far epothilone D has been the only brain-penetrant MT-stabilizer to be evaluated in tau transgenic mice and in AD patients. Furthermore, this...
Autores principales: | Lou, Kevin, Yao, Yuemang, Hoye, Adam T., James, Michael J., Cornec, Anne-Sophie, Hyde, Edward, Gay, Bryant, Lee, Virginia M.-Y., Trojanowski, John Q., Smith, Amos B., Brunden, Kurt R., Ballatore, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111403/ https://www.ncbi.nlm.nih.gov/pubmed/24992153 http://dx.doi.org/10.1021/jm5005623 |
Ejemplares similares
-
A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model
por: Zhang, Bin, et al.
Publicado: (2018) -
Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
por: Makani, Vishruti, et al.
Publicado: (2016) -
Multitargeted Imidazoles:
Potential Therapeutic Leads for Alzheimer’s and Other Neurodegenerative
Diseases
por: Cornec, Anne-Sophie, et al.
Publicado: (2017) -
Microtubule-Stabilizing
1,2,4-Triazolo[1,5-a]pyrimidines as Candidate
Therapeutics for Neurodegenerative
Disease: Matched Molecular Pair Analyses and Computational Studies
Reveal New Structure–Activity Insights
por: Alle, Thibault, et al.
Publicado: (2022) -
Structure-Activity Relationships, Tolerability and Efficacy of Microtubule-Active 1,2,4-Triazolo[1,5-a]pyrimidines as Potential Candidates to Treat Human African Trypanosomiasis
por: Monti, Ludovica, et al.
Publicado: (2023)